Registration number:
Menengai Medical Ltd
for the Year Ended 28 February 2023
Menengai Medical Ltd
(Registration number: 13192153)
Balance Sheet as at 28 February 2023
2023 |
2022 |
|
Fixed assets |
|
|
Current assets |
|
|
Prepayments and accrued income |
|
- |
Creditors: Amounts falling due within one year |
( |
( |
Net current assets |
|
|
Total assets less current liabilities |
|
|
Accruals and deferred income |
( |
( |
|
|
|
Capital and reserves |
|
|
For the financial year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
• |
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
|
Menengai Medical Ltd
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
UK
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
The financial statements are prepared in sterling, which is the functional currency of the company, and rounded to the nearest £.
Staff numbers |
The average number of persons employed by the company (including the director) during the year was
Related party transactions |
During the year a loan was made to the director. Interest was charged at 2% where applicable and the loan was repayable on demand.
Transactions with the director |
2023 |
At 1 March 2022 |
Advances to director |
Repayments by director |
At 28 February 2023 |
A Harris |
||||
|
( |
|
( |
( |
2022 |
At 10 February 2021 |
Advances to director |
Repayments by director |
At 28 February 2022 |
A Harris |
||||
|
- |
|
( |
( |